MA39111A1 - Dispositif oculaire - Google Patents
Dispositif oculaireInfo
- Publication number
- MA39111A1 MA39111A1 MA39111A MA39111A MA39111A1 MA 39111 A1 MA39111 A1 MA 39111A1 MA 39111 A MA39111 A MA 39111A MA 39111 A MA39111 A MA 39111A MA 39111 A1 MA39111 A1 MA 39111A1
- Authority
- MA
- Morocco
- Prior art keywords
- eye
- delivery device
- drug delivery
- polymer
- intraocular drug
- Prior art date
Links
- 229920000642 polymer Polymers 0.000 abstract 4
- 239000011159 matrix material Substances 0.000 abstract 3
- 239000011248 coating agent Substances 0.000 abstract 2
- 238000000576 coating method Methods 0.000 abstract 2
- 238000012377 drug delivery Methods 0.000 abstract 2
- 238000013268 sustained release Methods 0.000 abstract 2
- 239000012730 sustained-release form Substances 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 1
- 239000012530 fluid Substances 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A61K9/0051—Ocular inserts, ocular implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
- A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2240/00—Manufacturing or designing of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2240/001—Designing or manufacturing processes
- A61F2240/005—Templates
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Nanotechnology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Transplantation (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13192889 | 2013-11-14 | ||
| PCT/EP2014/074644 WO2015071427A1 (en) | 2013-11-14 | 2014-11-14 | Eye device |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA39111A1 true MA39111A1 (fr) | 2017-04-28 |
Family
ID=49584627
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA39111A MA39111A1 (fr) | 2013-11-14 | 2014-11-14 | Dispositif oculaire |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US9999595B2 (enExample) |
| EP (2) | EP3566693B1 (enExample) |
| JP (1) | JP6602761B2 (enExample) |
| KR (1) | KR20160085870A (enExample) |
| CN (1) | CN105792812B (enExample) |
| AU (1) | AU2014350095B9 (enExample) |
| BR (1) | BR112016010638B1 (enExample) |
| CA (1) | CA2929684C (enExample) |
| CL (1) | CL2016001160A1 (enExample) |
| EA (1) | EA032183B1 (enExample) |
| ES (2) | ES2864274T3 (enExample) |
| HK (1) | HK1223271A1 (enExample) |
| IL (1) | IL245405A0 (enExample) |
| MA (1) | MA39111A1 (enExample) |
| MX (1) | MX2016006142A (enExample) |
| TN (1) | TN2016000162A1 (enExample) |
| WO (1) | WO2015071427A1 (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10507101B2 (en) | 2014-10-13 | 2019-12-17 | W. L. Gore & Associates, Inc. | Valved conduit |
| EP3283004A4 (en) | 2015-04-13 | 2018-12-05 | Forsight Vision5, Inc. | Ocular insert composition of semi-crystalline or crystalline pharmaceutically active agent |
| US11351058B2 (en) | 2017-03-17 | 2022-06-07 | W. L. Gore & Associates, Inc. | Glaucoma treatment systems and methods |
| AU2019275406B2 (en) | 2018-05-24 | 2024-11-14 | Celanese Eva Performance Polymers Llc | Implantable device for sustained release of a macromolecular drug compound |
| SG11202005949UA (en) | 2018-05-24 | 2020-07-29 | Celanese Eva Performance Polymers Corp | Implantable device for sustained release of a macromolecular drug compound |
| WO2019222856A1 (en) | 2018-05-24 | 2019-11-28 | Nureva Inc. | Method, apparatus and computer-readable media to manage semi-constant (persistent) sound sources in microphone pickup/focus zones |
| US11298262B2 (en) | 2018-07-23 | 2022-04-12 | The Regents Of The University Of Colorado, A Body Corporate | Ophthalmic device for drug delivery |
| AU2019333136B2 (en) | 2018-08-29 | 2022-11-17 | W. L. Gore & Associates, Inc. | Drug therapy delivery systems and methods |
| US11678983B2 (en) | 2018-12-12 | 2023-06-20 | W. L. Gore & Associates, Inc. | Implantable component with socket |
| EP3990042A4 (en) | 2019-06-27 | 2023-07-19 | Layerbio, Inc. | METHODS AND SYSTEMS FOR RELEASING EYE DEVICES |
| US11399977B2 (en) | 2020-06-04 | 2022-08-02 | SpyGlass Pharma, Inc. | Ophthalmic implant system for drug delivery |
| US12472148B2 (en) | 2021-04-26 | 2025-11-18 | Celanese Eva Performance Polymers Llc | Implantable device for sustained release of a macromolecular drug compound |
| US20230149298A1 (en) * | 2021-11-17 | 2023-05-18 | Celanese Eva Performance Polymers Llc | Implantable Device for Treating an Inflammatory Eye Condition |
| CN114224822B (zh) * | 2022-01-28 | 2023-07-14 | 复旦大学附属眼耳鼻喉科医院 | 一种眼部缓释给药植入物及其制造方法 |
| EP4233836B1 (en) * | 2022-02-24 | 2024-11-06 | Eyed Pharma | Intraocular drug delivery device comprising an eyelet |
| US12285357B2 (en) | 2022-07-22 | 2025-04-29 | SpyGlass Pharma, Inc. | Intraocular drug delivery systems and methods of use |
| WO2024020505A2 (en) * | 2022-07-22 | 2024-01-25 | SpyGlass Pharma, Inc. | Intraocular drug delivery systems and methods of use |
| CN121038751A (zh) * | 2023-06-27 | 2025-11-28 | 博爱视觉有限责任公司 | 一种眼球植入体 |
| KR102783540B1 (ko) * | 2023-12-22 | 2025-03-17 | 조선대학교산학협력단 | 인공수정체 및 이의 제조방법 |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3416530A (en) | 1966-03-02 | 1968-12-17 | Richard A. Ness | Eyeball medication dispensing tablet |
| US3618604A (en) | 1969-06-09 | 1971-11-09 | Alza Corp | Ocular insert |
| US3710795A (en) | 1970-09-29 | 1973-01-16 | Alza Corp | Drug-delivery device with stretched, rate-controlling membrane |
| US4069307A (en) | 1970-10-01 | 1978-01-17 | Alza Corporation | Drug-delivery device comprising certain polymeric materials for controlled release of drug |
| US4014335A (en) | 1975-04-21 | 1977-03-29 | Alza Corporation | Ocular drug delivery device |
| US4144317A (en) | 1975-05-30 | 1979-03-13 | Alza Corporation | Device consisting of copolymer having acetoxy groups for delivering drugs |
| US4668506A (en) | 1985-08-16 | 1987-05-26 | Bausch & Lomb Incorporated | Sustained-release formulation containing and amino acid polymer |
| US4959217A (en) * | 1986-05-22 | 1990-09-25 | Syntex (U.S.A.) Inc. | Delayed/sustained release of macromolecules |
| US4718905A (en) * | 1986-08-13 | 1988-01-12 | Freeman Jerre M | Haptic element using ion beam implantation for an intraocular lens |
| US4997652A (en) | 1987-12-22 | 1991-03-05 | Visionex | Biodegradable ocular implants |
| US5164188A (en) | 1989-11-22 | 1992-11-17 | Visionex, Inc. | Biodegradable ocular implants |
| US5178635A (en) | 1992-05-04 | 1993-01-12 | Allergan, Inc. | Method for determining amount of medication in an implantable device |
| US5443505A (en) | 1993-11-15 | 1995-08-22 | Oculex Pharmaceuticals, Inc. | Biocompatible ocular implants |
| US5773019A (en) * | 1995-09-27 | 1998-06-30 | The University Of Kentucky Research Foundation | Implantable controlled release device to deliver drugs directly to an internal portion of the body |
| US5928282A (en) * | 1997-06-13 | 1999-07-27 | Bausch & Lomb Surgical, Inc. | Intraocular lens |
| US5902598A (en) * | 1997-08-28 | 1999-05-11 | Control Delivery Systems, Inc. | Sustained release drug delivery devices |
| FR2787991B1 (fr) | 1998-12-31 | 2001-05-25 | Medicale De Prec S M P Sa Soc | Dispositif pour traiter la presbytie ou autre affection oculaire |
| GB2399753B (en) * | 2002-01-18 | 2006-04-19 | Michael E Snyder | Method of making a sustained release ophthalmological device |
| FR2844703B1 (fr) | 2002-09-25 | 2005-07-08 | Alain Nicolas Gilg | Dispositif intraoculaire pour restaurer l'accommodation de l'oeil atteint de presbytie |
| US20090018650A1 (en) * | 2003-06-19 | 2009-01-15 | Boxer Wachler Brian S | Ophthalmological zonular stretch segment for treating presbyopia |
| JP2008535847A (ja) * | 2005-04-08 | 2008-09-04 | サーモディクス，インコーポレイティド | 網膜下に送達するための持続放出インプラント |
| WO2009140246A2 (en) * | 2008-05-12 | 2009-11-19 | University Of Utah Research Foundation | Intraocular drug delivery device and associated methods |
| EP2334285A1 (en) * | 2008-09-12 | 2011-06-22 | Critical Pharmaceuticals Limited | Improvements in the absorption of therapeutic agents across mucosal membranes or the skin |
| WO2010101758A1 (en) | 2009-03-03 | 2010-09-10 | Alcon Research, Ltd. | Peri-corneal drug delivery device |
| BR112012025581A2 (pt) * | 2010-04-06 | 2019-09-24 | Allergan Inc | implantes de reservatório de liberação sustentada para distribuição de fármaco intracameral |
-
2014
- 2014-11-14 HK HK16111409.4A patent/HK1223271A1/zh unknown
- 2014-11-14 CA CA2929684A patent/CA2929684C/en active Active
- 2014-11-14 ES ES19165620T patent/ES2864274T3/es active Active
- 2014-11-14 CN CN201480062417.9A patent/CN105792812B/zh active Active
- 2014-11-14 WO PCT/EP2014/074644 patent/WO2015071427A1/en not_active Ceased
- 2014-11-14 ES ES14809301T patent/ES2740352T3/es active Active
- 2014-11-14 MA MA39111A patent/MA39111A1/fr unknown
- 2014-11-14 BR BR112016010638-5A patent/BR112016010638B1/pt active IP Right Grant
- 2014-11-14 AU AU2014350095A patent/AU2014350095B9/en active Active
- 2014-11-14 KR KR1020167015621A patent/KR20160085870A/ko not_active Withdrawn
- 2014-11-14 EA EA201690967A patent/EA032183B1/ru not_active IP Right Cessation
- 2014-11-14 EP EP19165620.6A patent/EP3566693B1/en active Active
- 2014-11-14 EP EP14809301.6A patent/EP3068372B1/en active Active
- 2014-11-14 MX MX2016006142A patent/MX2016006142A/es unknown
- 2014-11-14 TN TN2016000162A patent/TN2016000162A1/en unknown
- 2014-11-14 US US15/034,869 patent/US9999595B2/en active Active
- 2014-11-14 JP JP2016531690A patent/JP6602761B2/ja active Active
-
2016
- 2016-05-02 IL IL245405A patent/IL245405A0/en unknown
- 2016-05-13 CL CL2016001160A patent/CL2016001160A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CL2016001160A1 (es) | 2017-03-17 |
| BR112016010638B1 (pt) | 2023-01-31 |
| EP3566693A1 (en) | 2019-11-13 |
| US9999595B2 (en) | 2018-06-19 |
| IL245405A0 (en) | 2016-06-30 |
| JP6602761B2 (ja) | 2019-11-06 |
| AU2014350095B9 (en) | 2019-09-12 |
| EP3566693B1 (en) | 2021-02-17 |
| EP3068372B1 (en) | 2019-05-08 |
| US20160287513A1 (en) | 2016-10-06 |
| CA2929684C (en) | 2022-02-22 |
| EA032183B1 (ru) | 2019-04-30 |
| ES2740352T3 (es) | 2020-02-05 |
| ES2864274T3 (es) | 2021-10-13 |
| JP2016537370A (ja) | 2016-12-01 |
| AU2014350095B2 (en) | 2019-08-29 |
| EP3068372A1 (en) | 2016-09-21 |
| CN105792812B (zh) | 2020-10-23 |
| WO2015071427A1 (en) | 2015-05-21 |
| AU2014350095A1 (en) | 2016-06-09 |
| TN2016000162A1 (en) | 2017-10-06 |
| CN105792812A (zh) | 2016-07-20 |
| HK1223271A1 (zh) | 2017-07-28 |
| BR112016010638A2 (enExample) | 2017-08-08 |
| MX2016006142A (es) | 2016-12-09 |
| KR20160085870A (ko) | 2016-07-18 |
| CA2929684A1 (en) | 2015-05-21 |
| EA201690967A1 (ru) | 2016-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA39111A1 (fr) | Dispositif oculaire | |
| USD839294S1 (en) | Display screen with graphical user interface for closed-loop medication delivery | |
| EP3999143A4 (en) | CLOSED ARTIFICIAL PANCREATIC DEVICE WITH INTEGRATED DETECTION AND INFUSION | |
| WO2008144340A3 (en) | Drug delivery system with scleral lens | |
| MA49677A (fr) | Dispositif d'administration de médicament avec module d'engrenage et procédé d'assemblage associé | |
| MA50614A (fr) | Dispositif d'administration de médicament comprenant un ensemble de verrouillage et procédé d'assemblage associé | |
| EP3793680C0 (en) | RADIOEMBOLIZATION DELIVERY DEVICE | |
| MA50553A (fr) | Dispositif d'administration de médicament avec détection de positionnement et de débit | |
| EP3478301A4 (en) | Manipulated parasites for the delivery of protein to the central nervous system (CNS) | |
| WO2014179568A3 (en) | Two-layer ocular implant | |
| MA51131A (fr) | Dispositif d'administration de médicament doté d'un système de détection de seringue | |
| EP2639626A3 (en) | Dynamic fluid zones in contact lenses | |
| RU2016148324A (ru) | Предварительно заполненный пластиковый шприц, содержащий антагонист vegf | |
| WO2012129407A3 (en) | Intraocular lens loading systems and methods of use | |
| EP3442481A4 (en) | SYSTEMS AND METHOD FOR DISPOSING MEDICAMENTS TO AN EYE | |
| EP3821012A4 (en) | Retrotransposon-based delivery vehicle and methods of use thereof | |
| WO2008141111A3 (en) | Polymers conjugated with platinum drugs | |
| MA55518A (fr) | Dispositif d'administration de médicament avec système de dosage à engrenages | |
| MA54245A (fr) | Système d'administration transdermique de médicaments à régulation thermique | |
| EP4049653A4 (en) | Injectable intraocular microgel as drug delivery system, and hydrogel comprising same | |
| EP3694497C0 (en) | Transdermal therapeutic system for the transdermal administration of guanfacine comprising a silicone acrylic hybrid polymer | |
| MY176039A (en) | Methods of treatment of ocular conditions with a sustained drug delivery implant | |
| MA55077A (fr) | Dispositif d'administration de médicament avec système de détection | |
| EP3801703A4 (en) | Tissue integrated drug delivery system | |
| EP3840710A4 (en) | Microneedle-array patches with glucose-responsive matrix for closed-loop insulin delivery |